期刊文献+

糖皮质激素治疗IgA肾病蛋白尿的meta分析 被引量:14

Glucocorticoid in treatment of proteinuria in IgA patients with nephropathy:a meta analysis
下载PDF
导出
摘要 目的通过meta分析探讨糖皮质激素对IgA肾病蛋白尿的疗效。方法检索Science Direct、EBSCO、Wiley、PubMed、CBMdisc、CNKI等数据文献库,收集1995-2013年国内外公开发表的以糖皮质激素作为随机对照试验治疗IgA肾病相关文献。采用固定效应模型计算标准化均数差(SMD)及95%置信区间(95%CI)。用Revman5.0软件从总体疗效、不同蛋白尿程度、不同疗程、不同肌酐值水平及联合ACEI等亚组进行Meta分析。结果共纳入9篇文献,包括256例激素组和273例对照组进行meta分析,结果显示:①糖皮质激素治疗IgA肾病蛋白尿的总体疗效优于对照组(P=0.000 01);②蛋白尿大于1.5 g/d和小于1.5 g/d的IgA肾病患者,糖皮质激素治疗蛋白尿的疗效均优于对照组(P<0.01);③对于血肌酐小于1.5mg/dl的IgA肾病患者,糖皮质激素治疗蛋白尿的疗效优于对照组(P<0.01);④糖皮质激素短程治疗(<1年)和长程治疗(≥1年)对于蛋白尿的疗效均优于对照组(P<0.01);⑤激素联合ACEI类药物对于蛋白尿的疗效更为显著(P<0.01)。结论糖皮质激素治疗IgA肾病蛋白尿总体疗效确切,对于不同程度蛋白尿的IgA肾病,激素治疗均有效,考虑不同疗程对于蛋白尿的疗效无明显影响,建议可适当缩短激素治疗疗程。激素联合ACEI较单纯应用ACEI类药物能更有效降低蛋白尿。 Abstract: Objective To explore the effect of glucocorticoid on proteinuria induced by IgA nephropathy.Methods Databases including Science Direct,EBSCO,Wiley,PubMed,CBMdisc,CNKI academic literature database,were searched from 1995 to 2011 to collect randomized controlled trials (RCTs) on glucocorticoid for IgA nephropathy.Standardized mean difference (SMD) with 95%confidence interval (95% CI) was calculated using fix effects models.Then Revman5.0 software was used to perform meta analysis in the overall effect,the degree of proteinuria,treatment cycle,creatinine levels and the effect of combined ACEI subgroup.Results A total of 9 articles were enrolled including 256 cases of glucocorticoid group and 273 cases of control group.①The overall efficacy in glucocorticoid group on proteinuria was better than in control group(P =0.000 01).②The efficacy in glucocorticoid patients with proteinuria higher than 1.5 g/d or lower than 1.5 g/d was superior to the controls(P 〈 0.01).③The efficacy of glucocorticoid treatment on proteinuria in IgA nephropathy serum creatinine level 〈 1.5 mg/dl was better than the controls(P 〈 0.01).④ The curative effect for proteinuria with glucocorticoid short-range treatment (〈 1 year) and long-term (≥ 1 year) was superior to that of the controls (P 〈0.01).⑤The efficacy of cormbined glucocorticoid with ACEI drugs on proteinuria was even more significant (P 〈 0.01).Conclusion The overall efficacy of glucocorticoid treatment for proteinuria caused by IgA nephropathy is exact.Glucocorticoid treatment is effective for different degrees of proteinuria.Considering no significandy different effect of different glucocorticoid treatment cycles,the treatment cycle can be shortened appropriately.Combined glucocorticoid and ACEI drugs is more effective for lowering proteinuria than ACEI drugs alone.
出处 《山西医科大学学报》 CAS 2013年第6期465-470,共6页 Journal of Shanxi Medical University
关键词 IGA肾病 糖皮质激素 META分析 蛋白尿 IgA nephropathy glucocorticoid meta analysis proteinuria
  • 相关文献

参考文献19

  • 1Julian BA,Waldo FB,Rifai A,et al.IgA nephropathy,the most common glomerulonephritis worldwide.A neglected disease in the United States[J].Am J Med,1988,84:129-132.
  • 2Srippoli G,Maione A,Tognoni G,et al.IgA Nephropathy:A disease in search of a large-scale clinical trial to reliably inform practice[J].Am J Kidney Dis,2009,53 (1):5-8.
  • 3NKF 2012 Spring Clinical Meetings Abstracts May 9-13,2012[J].Adv Chronic Kidney Dis,2012,19(2):120-121.
  • 4Pipili C,Pantelias K.Hemolytic-uremic syndrome,malignant hypertension and IgA nephropathy:Successful treatment with plasma exchange therapy[J].Transfus Apher Sci,2012,47 (2):155-158.
  • 5Kobayashi Y,Hiki Y,Kokubo T,et al.Steroid therapy during the early stage of progressive IgA nephropathy.A 10-year follow-up study[J].Nephron,1996,72:237-242.
  • 6Shoji T,Nakanishi I,Suzuki A,et al.Early treatment with corticosteroids ameliorates proteinuria,proliferative lesions and mesangial phenotypic modulation in adult diffuse proliferative IgA nephropathy[J].Am J Kidney Dis,2000,2:194-201.
  • 7Locatelli F,Pozzi C,Vecchio DL,et al.Role of proteinuria reductton in the progression of IgA nephropathy[J].Renal Failure,2001,23(3/4):495-505.
  • 8Uzu T,Harada T,Ko M,et al.Effect of corticosteroid therapy on the progression of IgA nephropathy with moderate proteinuria[J].Clin Exp Nephrol,2003,7:210-214.
  • 9Moriyama T,Honda K,Nitta K,et al.The effectiveness of steroid therapy for patients with advanced IgA nephropathy and impaired renal function[J].Clin Exp Nephrol,2004,8:237-242.
  • 10Hogg RJ,Lee J,Nardelli N,et al.Clinical trial to evaluate omega-3 fatty acids and alternate day prednisone in patients with IgA nephropathy:report from the Southwest Pediatric Nephrology Study Group[J].Clin J Am Soc Nephrol,2006,1:467-474.

同被引文献100

  • 1张希燃,王庆文,陈惠萍,曾彩虹,刘志红.大量蛋白尿型IgA肾病激素疗效及临床病理分析[J].医学研究生学报,2011,24(5):520-525. 被引量:7
  • 2陈香美,陈以平,李平,陈建,谌贻璞,周柱亮,陈威,赵宗江,危成筠,魏日胞,邓跃毅,李建军,杜婧,周瑾,何亚妮.1016例IgA肾病患者中医证候的多中心流行病学调查及相关因素分析[J].中国中西医结合杂志,2006,26(3):197-201. 被引量:231
  • 3周登余,徐星铭,戴宏,冯静.白芍总苷对大鼠系膜增生性肾小球肾炎的保护作用[J].安徽医科大学学报,2006,41(2):146-149. 被引量:29
  • 4李占亭,杨洁,孙脊峰,杜德伟,刘丽丽,王莉.IgA肾病的治疗进展[J].第四军医大学学报,2007,28(10):952-953. 被引量:11
  • 5陈华茜.膜性肾病的病因和诊断[J].中国医师进修杂志,2012,35(z1):219-220.
  • 6Shima Y, Nakanishi K, Hama T, et al. Validity of the Oxford clas- sification of IgA nephropathy in children [ J ]. Pediatr Nephrol, 2012,27 (5) :783-792.
  • 7Oakley RH, Revollo J, Cidlowski JA. Glucocorticoids regulate ar- restin gene expression and redirect the signaling profile of G pro- tein-coupled receptors[J]. Proc Natl Acad Sci U S A,2012,109 (43) : 17591-17596.
  • 8Donadio JV, Grande JP. IgA nephropathy. N Eng J Med, 2002, 374(2) :738.
  • 9Zheng YQ, Wei W. Total glucosides of paeony suppresses adju- vant arthritis in rats and intervenes cytokine - signaling between different types of synoviocytes. Int Immunopharmacol, 2005,5 (10) :1560 - 1573.
  • 10Yozai K, Shikata K, Sasaki M. Methotrexate prevents renal injury in experimental diabetic rats via anti- inflammatory actions. Journal of the American Society of Nephrology, 2005,16 ( 11 ) : 3326 - 3338.

引证文献14

二级引证文献82

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部